SALICYLIC ACID

Manufacturer
Sincerus Florida, LLC
Effective date
2019-05-16
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:28:47

Label at a glance#

ProductCICLOPIROX OLAMINE 0.77% / CLOBETASOL PROPIONATE 0.05% / SALICYLIC ACID 3%.
Active ingredientSALICYLIC ACID, CICLOPIROX OLAMINE, CLOBETASOL PROPIONATE
Label structure4 sections

Label contents#

Full prescribing information#

Directions for use

INSTRUCTIONS FOR USE SECTION

ssss

Sincerus Florida, LLC. Adverse reactions

ADVERSE REACTIONS SECTION

yujdyujd

Active, inactive

COMPONENTS

wwww

NDC 72934- 7039-6 CICLOPIROX OLAMINE USP 0.77% / CLOBETASOL PROPIONATE USP 0.05% / SALICYLIC ACID USP 3%. Shampoo 120gm

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

adad

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CICLOPIROX Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
CLOBETASOL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
20abe2c3-3e80-d2b2-39eb-3156e4af4799Product name320250124
45ad92f8-d116-4c0c-851c-2e740b7d8e6fProduct name120250122
42be0ad5-6fd7-4f1b-8108-6d9dd7d571dfProduct name720250107
3813b789-94b9-edd6-f010-6b926dd462e5Product name520230113
30eee8a1-850e-41ed-b5ab-761301aeab49Product name620221206
18e5b6f7-c414-b1f1-b684-17fdd02c215eProduct name420210927
1c87bbde-dd91-a122-db33-67ae814cb645Product name720210510
519b5875-7d7d-4aa6-9d3d-470fa1376595Product name420200227
d24c6245-86b5-4444-bc75-c1ac73ab3016Product name120180612
98669154-3e9c-47da-8a2c-656ab71848beProduct name220180607
8d4f8539-436f-453b-8b76-5322d403fc8eProduct name120180131
837ac3c6-ee71-c5a6-6eba-c4065f37e9f5Product name220171010
c7015f08-288e-4cfa-93b5-f4959a4814aeProduct name120150324
3f974526-143f-9d19-ee0c-98eeee0cdc3fProduct name120140508
5c035cac-559a-7171-c5cb-f0bd0d0fbc86Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-7039-62021-01-29C16284748780-1ba0f9c33-44fd-a910-e053-dadaa90a0b85CICLOPIROX OLAMINE 0.77% / CLOBETASOL PROPIONATE 0.05% / SALICYLIC ACID 3%.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-7039-6CICLOPIROX OLAMINE 0.77% / CLOBETASOL PROPIONATE 0.05% / SALICYLIC ACID 3%.120 g in 1 BOTTLE, PLASTICSHAMPOO1201

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-7039CICLOPIROX OLAMINE 0.77% / CLOBETASOL PROPIONATE 0.05% / SALICYLIC ACID 3%. SHAMPOO [SINCERUS FLORIDA, LLC]1Legacy NDC, 1 package rows20190517_89048552-4501-fcc6-e053-2995a90ace5b.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72934-7039-6GM - Gram72934-7039038d6d6a-384b-4dda-958a-a6520c1cd20012020-03-10

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72934-703972934-7039-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
89048552-4502-fcc6-e053-2995a90ace5b89048552-4501-fcc6-e053-2995a90ace5b2019-05-16Adverse reactionsExact identifier
spl id: 89048552-4502-fcc6-e053-2995a90ace5b
spl set id: 89048552-4501-fcc6-e053-2995a90ace5b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.